Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Waters ( (WAT) ).
Waters Corporation has filed a current report in connection with an upcoming Form S-3 shelf registration and has furnished detailed historical and pro forma financial information related to Becton, Dickinson and Company’s former Biosciences and Diagnostic Solutions business, which it acquired on February 9, 2026. The disclosure includes unaudited condensed combined financial statements for the SpinCo Business as of December 31, 2025 and September 30, 2025, management’s discussion and analysis for fiscal years 2023–2025 and the quarter ended December 31, 2025, and unaudited pro forma results for Waters and the acquired business for 2025, giving investors greater visibility into the financial impact of the recent acquisition and the combined company’s capital markets plans.
The most recent analyst rating on (WAT) stock is a Hold with a $312.00 price target. To see the full list of analyst forecasts on Waters stock, see the WAT Stock Forecast page.
Spark’s Take on WAT Stock
According to Spark, TipRanks’ AI Analyst, WAT is a Neutral.
The score is driven primarily by strong underlying profitability and cash generation, plus a constructive 2026 outlook and synergy plan from the BD combination. These positives are tempered by very weak near-term technicals (below key moving averages with negative momentum) and a premium valuation (P/E ~30.5), with added integration and leverage risks flagged in guidance.
To see Spark’s full report on WAT stock, click here.
More about Waters
Waters Corporation is a U.S.-based life sciences and analytical instruments company that provides chromatography, mass spectrometry, and related laboratory solutions to pharmaceutical, biotech, diagnostics, and industrial customers. The company focuses on enabling advanced analytical testing and diagnostics, positioning itself as a key supplier to regulated and research-driven markets worldwide.
Average Trading Volume: 1,006,391
Technical Sentiment Signal: Sell
Current Market Cap: $28.11B
Find detailed analytics on WAT stock on TipRanks’ Stock Analysis page.